Skip to main content

CSS LLC/IL

Position in BIIB — Biogen Inc.

CIK 1103646 CHICAGO, IL

Position in BIIB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$622,252
+$123,595 QoQ
Shares Held
2,880
+5.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#535
of 1,036 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Derivatives in BIIB

reported options exposure · as of Dec 31, 2022
CallValue
$4,679,948
CallShares
16,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CSS LLC/IL holds $6,263,567 across 6 Drug Manufacturers - General names. BIIB ranks #6 (9.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 BIIB
Biogen Inc.
This page
2,880 $622,252

All Filings in BIIB

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $622,252 2,880
2026-03-31 $498,657 2,720
2025-12-31 $1,070,019 6,080
2025-09-30 $1,085,620 7,750
2025-06-30 $869,082 6,920
2025-03-31 $510,413 3,730
2022-12-31 $4,679,948 16,900
2022-09-30 $6,301,200 23,600
2022-09-30 $8,277,000 31,000
2022-09-30 $1,702,926 6,378
2022-03-31 $2,211,300 10,500
2021-12-31 $671,776 2,800
2021-12-31 $11,372,208 47,400
2021-12-31 $2,639,120 11,000
2021-09-30 $650,877 2,300
2021-09-30 $3,763,767 13,300
2021-06-30 $3,982,105 11,500
2021-06-30 $8,656,750 25,000
2021-06-30 $634,366 1,832
2021-03-31 $29,233,875 104,500
2021-03-31 $3,111,099 11,121
2020-12-31 $50,196,300 205,000
2020-12-31 $3,694,692 15,089
2020-12-31 $6,317,388 25,800
2020-09-30 $6,808,320 24,000
2020-09-30 $13,531,536 47,700
2020-06-30 $5,135,889 19,196
2020-06-30 $214,040 800
2020-06-30 $9,096,700 34,000
2020-03-31 $7,593,120 24,000
2020-03-31 $885,864 2,800
2020-03-31 $259,431 820